| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |